Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Patricia Tung"'
Autor:
Juliana Pérez-Pinzón, MD, Jonathan W. Waks, MD, Don Yungher, PhD, Abigail Reynolds, BA BE, Timothy Maher, MD, Andrew H. Locke, MD, Andre d'Avila, MD, Patricia Tung, MD, MPH
Publikováno v:
Heart Rhythm O2, Vol 5, Iss 10, Pp 713-719 (2024)
Background: Pulmonary vein isolation (PVI) is superior to antiarrhythmics for the management of atrial fibrillation, but repeat ablation is often required for durable rhythm control. Factors influencing first-pass isolation (FPI) and whether FPI pred
Externí odkaz:
https://doaj.org/article/1f59e889b5b84b8dbd179161d09de784
Autor:
Patricia Tung, MD, Jonathan W. Waks, MD, Sankalp Sehgal, MD, Alfred E. Buxton, MD, Andre D’Avila, MD
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 4, Pp 341-346 (2021)
Background: High-frequency jet ventilation (HFJV) is used during pulmonary vein isolation (PVI) to increase catheter stability and improve outcomes. In prior studies, hemodynamic intolerance to HFJV was rare. Objectives: To evaluate the incidence of
Externí odkaz:
https://doaj.org/article/e56f1e5c80864275a3b3c15385b7c51a
Autor:
Robert N. D’Angelo, Rahul Khanna, Robert W. Yeh, Laura Goldstein, Iftekhar Kalsekar, Stephen Marcello, Patricia Tung, Peter J. Zimetbaum
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Catheter ablation (CA) has emerged as an effective treatment for symptomatic atrial fibrillation (AF). However practice patterns and patient factors associated with referral for CA within the first 12 months after diagnosis are po
Externí odkaz:
https://doaj.org/article/c685c750cc80445a9e6e23fc701c543a
Autor:
Patricia Tung, Yamini S. Levitzky, Rui Wang, Jia Weng, Stuart F. Quan, Daniel J. Gottlieb, Michael Rueschman, Naresh M. Punjabi, Reena Mehra, Suzie Bertisch, Emelia J. Benjamin, Susan Redline
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 7 (2017)
BackgroundPrevious studies have documented a high prevalence of atrial fibrillation (AF) in individuals with obstructive sleep apnea (OSA). Central sleep apnea (CSA) has been associated with AF in patients with heart failure. However, data from prosp
Externí odkaz:
https://doaj.org/article/6d39f294ae654cc59d691e43cc62708d
Publikováno v:
The American Journal of Cardiology. 182:25-31
Sleep apnea (SA) is recognized as a predictor of incident atrial fibrillation (AF) and AF recurrence after treatment. However, data on the prevalence of SA phenotypes in patients with AF and the effect of widespread SA screening on AF outcomes are sc
Autor:
Alice, Haouzi, Mark, Tuttle, Allon, Eyal, Kunal, Tandon, Patricia, Tung, Peter J, Zimetbaum, Daniel B, Kramer
Publikováno v:
Journal of Interventional Cardiac Electrophysiology. 64:195-202
Limited evidence guides management of conduction abnormalities following TAVR. Standardized clinical pathways may reduce variability in care while minimizing bradyarrhythmic morbidity, length of stay (LOS), and pacemaker (PPM) implantation rates.A mu
Autor:
Shu Yang, Davis Sneider, Robert N. D'Angelo, Andrew H. Locke, Bahij Kreidieh, Timothy R. Maher, Nicholas O. Palmeri, Hans F. Stabenau, Michael Barkagan, Daniel A. McKelvey, Alfred E. Buxton, Charles I. Haffajee, Kapil Kumar, Andre d`Avila, Patricia Tung
Publikováno v:
Heart Rhythm. 20:S463-S464
Autor:
Andrew H. Locke, Shu Yang, Robert N. D'Angelo, Timothy R. Maher, Ronuk Modi, Bahij Kreidieh, Nicholas O. Palmeri, Hans F. Stabenau, Dana Goldense, Emily Wacks, Marianna Lozano Cruz Marques, Steven M. Shiner, Robert Collins, Patricia Tung, Jonathan W. Waks, Andre d`Avila, Peter J. Zimetbaum
Publikováno v:
Heart Rhythm. 20:S593-S594
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 4, Pp 341-346 (2021)
Heart Rhythm O2
Heart Rhythm O2
Background High-frequency jet ventilation (HFJV) is used during pulmonary vein isolation (PVI) to increase catheter stability and improve outcomes. In prior studies, hemodynamic intolerance to HFJV was rare. Objectives To evaluate the incidence of he
Autor:
Patricia Tung, Peter Zimetbaum, Motiur Rahman, Sashi Yadalam, Robert W. Yeh, Laura Goldstein, Robert N. D'Angelo, Rahul Khanna, Iftekhar Kalsekar
Publikováno v:
Journal of Cardiovascular Electrophysiology. 32:1529-1537
Introduction Antiarrhythmic drugs (AADs) are commonly used for the treatment of newly-diagnosed symptomatic atrial fibrillation (AF), however initial AAD choice, duration of therapy, rates of discontinuation and factors associated with a durable resp